Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

EH Stock Alert: EHang Announces UAE Expansion, New Partnership

By Josh Enomoto, InvestorPlace Contributor

With eVTOL specialist EHang inking a partnership with a UAE-based enterprise, EH stock may rise amid a challenging ecosystem.

Why Is SunPower (SPWR) Stock Down 35% Today?

By Josh Enomoto, InvestorPlace Contributor

Although SunPower is suffering a devastating loss today due to a credit agreement breach, all may not be lost for SPWR stock.

The 3 Best Performing Stocks of 2023

By Josh Enomoto, InvestorPlace Contributor

After a tough year in the equities space in 2022, the market rebounded quite robustly, warranting a discussion of the best performing stocks of 2023.…

3 Very Undervalued Stocks With Strong Growth Prospects

By Josh Enomoto, InvestorPlace Contributor

While the forward-looking mood for the equities sector may be pivoting in a positive direction, there are still opportunities among undervalued stocks with strong growth…

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar

By Josh Enomoto, InvestorPlace Contributor

With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like…

RKLB Stock Alert: Rocket Lab Breaks Annual Launch Record

By Josh Enomoto, InvestorPlace Contributor

Although Rocket Lab enjoyed a milestone successful launch recently, RKLB stock stumbled, likely on profitability concerns.

Why Is Verrica Pharmaceuticals (VRCA) Stock Up 40% Today?

By Josh Enomoto, InvestorPlace Contributor

With Verrica Pharmaceuticals releasing positive Phase 3 trial results for a skin disease therapeutic, VRCA stock skyrocketed in response.

3 Overvalued Tech Stocks to Sell Before They Tank

By Josh Enomoto, InvestorPlace Contributor

After witnessing the blistering returns of the broader technology index – along with tangentially related risk-on assets like cryptocurrencies – now might seem an unideal…

Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight

By Josh Enomoto, InvestorPlace Contributor

While your typical financial advisor will likely direct you to focus on established blue chips to boost your holdings, few other compelling options exist other…

7 Promising Penny Stocks With the Potential to Defy Expectations

By Josh Enomoto, InvestorPlace Contributor

You know you want it. High-potential penny stocks that is. And I’m here to deliver. However, from an obligatory standpoint, I must warn you from…

Load More